GNQ Insilico, a California‑based Techbio company transforming pre‑clinical and clinical development through AI‑driven digital twins and quantum‑enhanced in silico trials.GNQ’s Digital Twins Platform b
...
Guidant BioTherapeutics is a clinical-stage oncology company advancing a differentiated pipeline of dual-cytokine immunotherapies andnext-generation dual-targeting dual-toxin antibody-drug conjugates
...
Gan & Lee (market cap of US$ 4bn) is the #1 domestic insulin supplier in China with 10 commercial products in 19 countriesWorld-class E. coli fermentation system and leading purification technologyTwo
...
GATC Health is a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% se
...
At Gordian we have scaled in vivo perturb-seq, toward curing chronic diseases. Using our proprietary discovery technology, we measure in vivo efficacy of hundreds of novel targets simultaneously, in i
...
Global Emerging Markets (“GEM”) is a $3.4 billion alternative investment group that manages a diverse set of investment vehicles focused on emerging markets across the world.
)
)
)
){kind=logo}
